A modular design of two-pronged sub-organelle targeting strategy disrupting mitochondria-endoplasmic reticulum crosstalk for mitigating rheumatoid arthritis

Apr 10, 2026Biomaterials

A two-part strategy targeting specific cell parts to disrupt communication between energy and protein systems for reducing rheumatoid arthritis

AI simplified

Longevity & Aging on OpenScience ↗PubMed ↗DOI ↗

Abstract

The optimal two-pronged nanoplatform Res@DPGT significantly alleviates rheumatoid arthritis by disrupting aberrant mitochondria-associated endoplasmic reticulum membranes.

Res@DPGT delivers therapeutic resveratrol to both the endoplasmic reticulum and mitochondria in inflammatory cells.
In inflammatory cells, Res@DPGT suppresses endoplasmic reticulum stress and mitochondrial dysfunction.
Res@DPGT enhances the internalization of therapeutic agents by circulating monocytes, leading to targeted distribution in inflamed joints.
Administration of Res@DPGT results in prolonged retention of the therapy in affected areas.
The approach addresses limitations of single organelle-targeted therapies by employing a minimalist modular design.

AI simplified

The pathological crosstalk between endoplasmic reticulum (ER) stress and mitochondria (MT) dysfunction aggravates rheumatoid arthritis (RA) process by promoting the abnormal formation of mitochondria-associated ER membranes (MAMs). Current single organelle-specific therapies are insufficient to halt MAMs-mediated pathological inter-organelle communication and thereby showed limited efficacy in suppressing RA. A two-pronged dual organelles regulatory strategy that concurrently inhibit ER stress and MT dysfunction, thereby suppressing the aberrant MAMs formation will be promising to achieve prolonged RA remission. Due to the multiple delivery barriers from tissue to sub-organelle level, conventional approaches involve decorating nanocarriers with multiple functional groups. However, this typically leads to increased structural complexity and unpredictable in vivo performance. Here, we adopted a minimalist modular design strategy. By fine-tuning the density and ratio of dual organelles-targeted modules, we optimized the physicochemical properties of the Res@DPGT nanoplatform for maximal sub-organelle drug delivery. The optimal two-pronged nanoplatform Res@DPGT achieve a hierarchical targeting process from the tissue level to sub-organelle level, ultimately delivering therapeutic resveratrol (Res) to ER and MT. In inflammatory cells, Res@DPGT significantly suppress ER stress and MT dysfunction by disrupting MAMs formation, eliciting potent anti-inflammatory efficacy. In arthritic rats, intravenously administrated Res@DPGT show enhanced internalization by circulating monocytes and leverage the inflammatory tropism of circulating monocytes to achieve preferential distribution and prolonged retention in inflamed joints. Ultimately, Res@DPGT remarkedly alleviate RA by disrupting the MAMs-mediated pathological ER-MT coupling.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

A modular design of two-pronged sub-organelle targeting strategy disrupting mitochondria-endoplasmic reticulum crosstalk for mitigating rheumatoid arthritis

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief